Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance

29 Aug 2023

Abstract excerpt

BACKGROUND: Glioma is a lethal brain cancer and lacking effective therapies. Challenges include no effective therapeutic target, intra- and intertumoral heterogeneity, inadequate effective drugs, and an immunosuppressive microenvironment, etc. Deciphering the pathogenesis of gliomas and finding out the working mechanisms are urgent and necessary for glioma treatment. Identification of prognostic biomarkers and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Caveolin-1 and cellular processes
Share to Extracellular vesicles in disease
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37642765
DOI: 10.1007/s12672-023-00765-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistancePMID 37642765Read ↗

Integrated profiling identifies caveolae‐associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patientsSemantic proximity Read ↗

The role of caveolin-1 in tumors of the brain - functional and clinical implicationsSemantic proximity Read ↗

Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterationsSemantic proximity Read ↗

Novel prognostic features and personalized treatment strategies for mitochondria-related genes in glioma patientsSemantic proximity Read ↗

VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagySemantic proximity Read ↗

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in gliomaSemantic proximity Read ↗

SLC1A5 Enhances Malignant Phenotypes Through Modulating Ferroptosis Status and Immune Microenvironment in GliomaSemantic proximity Read ↗

Development of an oxidative phosphorylation signature in high-grade glioma and screening of potential inhibitorsSemantic proximity Read ↗

A Nomogram Model Incorporating PVALB Expression for Individualized Prognostic Prediction in GliomaSemantic proximity Read ↗

Redox-Regulated Pathways in Glioblastoma Stem-like Cells: Mechanistic Insights and Therapeutic ImplicationsSemantic proximity Read ↗

GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesSemantic proximity Read ↗

Role of KCNB1 in the prognosis of gliomas and autophagy modulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.